New York, New York (PRWEB) September 25, 2013
Biomet hip lawsuits (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) involving the M2a Magnum hip continue to move forward in the federal multidistrict litigation underway in U.S. District Court, Northern District of Indiana. According to a Memorandum issued on September 24th, the Court recently held a Status Conference, at which time a number of issues were discussed, including selection of bellwether cases, and pending and future dispositive motions. The Court also informed the parties that it will issue an order prior to the next conference regarding the selection of Biomet hip replacement claims for the proceeding’s first bellwether trials, as well as plaintiffs' request to appoint a special master for discovery. The next conference will be conducted via telephone on November 18th, according to the Order. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“Our Firm is representing several Biomet hip replacement plaintiffs in this proceeding. We are pleased to see these cases moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential Biomet hip lawsuit evaluations to individuals who may have been injured by this Biomet M2a Magnum hip.
Biomet Hip Replacement Litigation
According to court documents, 652 Biomet hip replacement claims are now pending in the litigation underway in Indiana. The Biomet M2a Magnum is a metal-on-metal hip replacement system in which the ball and cup are made from a chromium cobalt alloy. Plaintiffs who have filed Biomet hip lawsuits allege that this design can cause the hip to shed dangerous amounts of metal debris, leading to serious complications, including metallosis, premature failure of the device, and significant bone and tissue loss. Many of those involved in the litigation have had to undergo revision surgery to have their M2a Magnum device removed and replaced, yet continue to suffer disability as a result of their alleged injuries.
In January 2013, the U.S. Food & Drug Administration (FDA) warned that metal-on-metal hip implants had been associated with higher rates of early failure compared to those composed of other materials. In addition to proposing new regulations that would subject such implants to more regulatory oversight, the FDA has advised recipients of all-metal hips to undergo metal ion blood testing if they experience any symptoms that would indicate their device could be failing.
Recipients of the Biomet M2a Magnum hip who have allegedly experienced serious complications related to its metal-on-metal design may be entitled to compensation for medical bills, lost wages, pain and suffering, and other damages. Learn More about the Biomet M2a Magnum and other metal-on-metal hips at Bernstein Liebhard LLP’s website. For additional information and a free case review, please call one our attorneys today at 800-511-5092
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP